Mengjie Hu

1.7k total citations · 1 hit paper
25 papers, 1.0k citations indexed

About

Mengjie Hu is a scholar working on Molecular Biology, Immunology and Epidemiology. According to data from OpenAlex, Mengjie Hu has authored 25 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Immunology and 6 papers in Epidemiology. Recurrent topics in Mengjie Hu's work include Respiratory viral infections research (6 papers), interferon and immune responses (5 papers) and Nuclear Receptors and Signaling (4 papers). Mengjie Hu is often cited by papers focused on Respiratory viral infections research (6 papers), interferon and immune responses (5 papers) and Nuclear Receptors and Signaling (4 papers). Mengjie Hu collaborates with scholars based in China, United States and Australia. Mengjie Hu's co-authors include Chuan‐Yuan Li, Xuhui Bao, Meng Jiao, Fang Li, David A. Jans, Marie A. Bogoyevitch, Dong Pan, Jin Cheng, Qian Huang and Xinjian Liu and has published in prestigious journals such as Nature, Journal of Clinical Investigation and Physiological Reviews.

In The Last Decade

Mengjie Hu

25 papers receiving 1.0k citations

Hit Papers

Inhibition of PCSK9 potentiates immune checkpoint therapy... 2020 2026 2022 2024 2020 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mengjie Hu China 14 455 347 226 183 164 25 1.0k
Weicheng Wu China 19 892 2.0× 407 1.2× 203 0.9× 301 1.6× 98 0.6× 41 1.3k
Devram Sampat Ghorpade India 12 428 0.9× 283 0.8× 118 0.5× 227 1.2× 247 1.5× 12 992
Chunbin Zou United States 22 1.0k 2.3× 364 1.0× 168 0.7× 150 0.8× 271 1.7× 52 1.5k
Xiaofei Yu United States 22 656 1.4× 708 2.0× 257 1.1× 154 0.8× 144 0.9× 41 1.4k
Zhihua Ruan China 21 391 0.9× 400 1.2× 318 1.4× 196 1.1× 162 1.0× 50 1.1k
Júlia Varga Germany 15 538 1.2× 134 0.4× 337 1.5× 167 0.9× 86 0.5× 18 1000
Jean‐Pierre Couty France 16 417 0.9× 204 0.6× 248 1.1× 108 0.6× 296 1.8× 29 1.1k
Adam M. Farkas United States 12 643 1.4× 431 1.2× 209 0.9× 107 0.6× 400 2.4× 23 1.4k
Tsutomu Tanaka Japan 19 428 0.9× 169 0.5× 123 0.5× 120 0.7× 227 1.4× 36 996
Yongxue Yao United States 18 504 1.1× 604 1.7× 242 1.1× 182 1.0× 118 0.7× 30 1.4k

Countries citing papers authored by Mengjie Hu

Since Specialization
Citations

This map shows the geographic impact of Mengjie Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengjie Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengjie Hu more than expected).

Fields of papers citing papers by Mengjie Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mengjie Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengjie Hu. The network helps show where Mengjie Hu may publish in the future.

Co-authorship network of co-authors of Mengjie Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Mengjie Hu. A scholar is included among the top collaborators of Mengjie Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mengjie Hu. Mengjie Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cai, Qi, Mengjie Hu, Bo Rao, et al.. (2024). Multi-omics insights into the microbiota-gut-brain axis and cognitive improvement post-bariatric surgery. Journal of Translational Medicine. 22(1). 945–945. 4 indexed citations
2.
Jiao, Meng, Mengjie Hu, Dong Pan, et al.. (2024). VHL loss enhances antitumor immunity by activating the anti-viral DNA-sensing pathway. iScience. 27(7). 110285–110285. 2 indexed citations
3.
Hu, Mengjie, Marie A. Bogoyevitch, & David A. Jans. (2023). Respiratory Syncytial Virus Matrix Protein Is Sufficient and Necessary to Remodel Host Mitochondria in Infection. Cells. 12(9). 1311–1311. 8 indexed citations
4.
Pan, Dong, Xuhui Bao, Mengjie Hu, et al.. (2022). SETDB1 Restrains Endogenous Retrovirus Expression and Antitumor Immunity during Radiotherapy. Cancer Research. 82(15). 2748–2760. 31 indexed citations
5.
Bao, Xuhui, Xinjian Liu, Mengjie Hu, et al.. (2021). Abstract NG12: From cholesterol regulation to tumor suppression: Pcsk9 as a novel target for cancer immunotherapy. Cancer Research. 81(13_Supplement). NG12–NG12. 1 indexed citations
6.
Li, Hongmei, Reena Ghildyal, Mengjie Hu, et al.. (2021). Respiratory Syncytial Virus Matrix Protein-Chromatin Association Is Key to Transcriptional Inhibition in Infected Cells. Cells. 10(10). 2786–2786. 13 indexed citations
7.
Wang, Hao, et al.. (2020). Acupuncture at Gastric Back‐Shu and Front‐Mu Acupoints Enhances Gastric Motility via the Inhibition of the Glutamatergic System in the Hippocampus. Evidence-based Complementary and Alternative Medicine. 2020(1). 3524641–3524641. 5 indexed citations
8.
Liu, Xinjian, Mengjie Hu, Pei Liu, et al.. (2020). ATM Paradoxically Promotes Oncogenic Transformation via Transcriptional Reprogramming. Cancer Research. 80(8). 1669–1680. 12 indexed citations
9.
Hu, Mengjie, Marie A. Bogoyevitch, & David A. Jans. (2020). Impact of Respiratory Syncytial Virus Infection on Host Functions: Implications for Antiviral Strategies. Physiological Reviews. 100(4). 1527–1594. 47 indexed citations
10.
Liu, Xinjian, Xuhui Bao, Mengjie Hu, et al.. (2020). Inhibition of PCSK9 potentiates immune checkpoint therapy for cancer. Nature. 588(7839). 693–698. 331 indexed citations breakdown →
11.
Hu, Mengjie, Min Zhou, Xuhui Bao, et al.. (2020). ATM inhibition enhances cancer immunotherapy by promoting mtDNA leakage and cGAS/STING activation. Journal of Clinical Investigation. 131(3). 173 indexed citations
12.
Hu, Mengjie, Marie A. Bogoyevitch, & David A. Jans. (2019). Subversion of Host Cell Mitochondria by RSV to Favor Virus Production is Dependent on Inhibition of Mitochondrial Complex I and ROS Generation. Cells. 8(11). 1417–1417. 45 indexed citations
13.
Hu, Mengjie, Hao Wang, Liu Wang, Xiaole Wang, & Guo-Ming Shen. (2019). [Role of hippocampus NMDAR subunits in electroacupuncture at "Zhongwan" (CV 12) and "Weishu" (BL 21) for gastric motility].. PubMed. 39(5). 507–13. 3 indexed citations
15.
Hu, Mengjie, Gulimiran Alitongbieke, Ying Su, Hu Zhou, & Xiao-kun Zhang. (2017). Moving nuclear receptor Nur77 to damaged mitochondria for clearance by mitophagy. Molecular & Cellular Oncology. 5(3). e1327005–e1327005. 3 indexed citations
16.
Hu, Mengjie, Hongmei Li, Marie A. Bogoyevitch, & David A. Jans. (2017). Mitochondrial protein p32/HAPB1/gC1qR/C1qbp is required for efficient respiratory syncytial virus production. Biochemical and Biophysical Research Communications. 489(4). 460–465. 25 indexed citations
17.
Liu, Jie, Guanghui Wang, Yinghui Duan, et al.. (2017). Modulation of the Nur77-Bcl-2 apoptotic pathway by p38α MAPK. Oncotarget. 8(41). 69731–69745. 19 indexed citations
18.
Chen, Fan, Jiebo Chen, Jiacheng Lin, et al.. (2015). NSC-640358 acts as RXRα ligand to promote TNFα-mediated apoptosis of cancer cell. Protein & Cell. 6(9). 654–666. 8 indexed citations
19.
Hu, Mengjie, Jie Liu, Shun‐Lin Li, et al.. (2014). Cardiac glycosides from the bark of Antiaris toxicaria. Fitoterapia. 97. 71–77. 24 indexed citations
20.
Tang, Jinshan, Mengjie Hu, Jie Liu, et al.. (2013). Antiproliferative Cardiac Glycosides from the Latex of Antiaris toxicaria. Journal of Natural Products. 76(9). 1771–1780. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026